Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III placebo-controlled trial of celecoxib in genotype-positive subjects with familial adenomatous polyposis
2006-002228-40Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Colonic Adenomatous Polyposis comparing Celecoxib arm with Placebo arm (2 arms). Primary endpoint: Time to treatment failure. Started Jun 2006; status: terminated.
02
Drugs
celecoxib
03
Conditions
Colonic Adenomatous Polyposis
Beyond the preview
Go deeper on 2006-002228-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002228-40.